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Evidence Based Medicine
A 10-year stroke prevention after successful carotid
endarterectomy for asymptomatic stenosis (ACST-1): a
multicentre randomized trial is reviewed.
Why is this study of clinical importance?
Asymptomatic patients with substantial (eg, 60-
90%) carotid artery narrowing but no recent neurological
symptoms are at increased long-term risk of ischaemic
stroke, especially in parts of the brain supplied by that artery
(the ipsilateral carotid territory). Carotid endarterectomy
(CEA) can remove the arterial narrowing, but the procedure
itself causes some immediate risk of:
Stroke or death.
ACAS investigators designed a study to find out
whether the addition of CE to aspirin plus risk factor
modifications will affect the incidence of TIA or infarctions
in patients withasymptomatic but haemodynamically
significant carotid stenosis in at least one artery in 1987.
This study randomly assigned patients during 1993-2003 to
immediate CEA or deferral of any carotid artery procedure
until a more definite indication was thought to have arisen,
and followed them up until 2006-08. In 2004, ACST-1
reported the medium-term benefits of CEA during the first
few years after randomization. This article describes the
immediate hazards and 10-year benefits of CEA,
subdividing the benefits by participants' characteristics and
medical treatment.
Who were the participants?
In asymptomatic patients with substantial carotid
artery narrowing, ACST-1 compared immediate CEA versus
deferral. All other aspects of treatment were left to the
clinician, but usually included long-term antithrombotic
therapy, antihypertensive therapy, and, particularly in recent
years, lipid-lowering therapy. In all 126 centers in 30
countries participated. Patients were eligible if: (1) they had
severe unilateral or bilateral carotid artery stenosis
(generally carotid artery diameter reduction at least 60%,
although there was no fixed minimum percentage); (2) this
stenosis had not caused stroke, transient cerebral ischaemia,
or any other relevant neurological symptoms in the past 6
months; (3) no circumstance or condition precluded long-
term follow-up; and (4) doctor and patient were both
substantially uncertain whether to choose immediate CEA
or deferral of any CEA. A total of 3120 patients entered the
study between April, 1993, and July, 2003, with no
significant differences in baseline characteristics between
those randomly allocated immediate CEA and deferral.
What was the intervention?
In asymptomatic patients with substantial carotid
artery narrowing, ACST-1 compared immediate CEA versus
deferral. All other aspects of treatment were left to the
clinician, but usually included long-term antithrombotic
therapy, antihypertensive therapy, and, particularly in recent
years, lipid-lowering therapy. They allocated patients
equally to immediate CEA or deferral of any carotid surgery
by minimized randomization.
Follow-up was scheduled at 4 months and 12 months
and then yearly until 2006-08, irrespective of any nonfatal
strokes.
What was the outcome?
In all 1560 patients were allocated immediate CEA
versus 1560 allocated deferral of any carotid procedure. The
proportions operated on while still asymptomatic were
89·7% versus 4·8% at 1 year (and 92·1% vs16·5% at 5
years).
Perioperative risk of stroke or death within 30 days
was 3·0% (95% CI 2·4-3·9; 26 non-disabling strokes plus 34
disabling or fatal perioperative events in 1979 CEAs).
Excluding perioperative events and non-stroke mortality,
stroke risks (immediate vs deferred CEA) were 4·1% versus
10·0% at 5 years (gain 5·9%, 95% CI 4·0-7·8) and 10·8%
versus 16·9% at 10 years (gain 6·1%, 2·7-9·4); ratio of
stroke incidence rates 0·54, 95% CI 0·43-0·68, p<0·0001.
The results showed that 62 versus 104 had a disabling or
fatal stroke, and 37 versus 84 others had a non-disabling
stroke. Combining perioperative events and strokes, net
risks were 6·9% versus 10·9% at 5 years (gain 4·1%, 2·0-
6·2) and 13·4% versus 17·9% at 10 years (gain 4·6%, 1·2-
7·9). Medication was similar in both groups; throughout the
study, most were on antithrombotic and antihypertensive
therapy. Net benefits were significant, both for those on
lipid-lowering therapy and for those not, and both for men
and for women up to 75 years of age at entry (although not
for older patients).
What were the conclusions?
Successful CEA for asymptomatic patients younger
than 75 years of age reduces 10 year stroke risks.Half this
reduction is in disabling or fatal strokes. Net benefit in
future patients will depend on their risks from unoperated
carotid lesions (which will be reduced by medication), on
future surgical risks ( which might differ from those in
trials), and on whether life expectancy exceeds 10 years.
How does this impact us?
For men and women younger than 75 years with
asymptomatic stenosis,successful carotid surgery could
usefully add to the beneficial effects of good medical therapy
(antihypertensive and stating regimen) in reducing long term
stroke risks as long as perioperative risks remain low. This is
especially in patients who would otherwise have more than
10 years of reasonable life expectancy. We need to be aware
of the local risks and benefits before we can routinely
recommend this procedure due to the perioperative risks. 
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